AstraZeneca likely won't be first coronavirus vaccine to market but could be most widely available

Drugmaker AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world.